chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SIDE EFFECTS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced side effects. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of side effects was not reported. This report was non-serious.
pt recvd vax;c/o pain in rt deltoid area the noc of vax;pain cont x 1 wk w/ limited mobility noted of rt arm;no swelling/redness;to PMD;tx w/ anti-inflam meds x 10 days w/ almost complete recovery;
Within 5-7 days after receiving flu vaccine, patients reports having searing pain and decreased strength to left arm as well as decreased ROM. Site of injection tender to touch.
Heart rate speed up to over 180 beats a minute.  Fatigue.  Out of breath.    Felt horrible for two days prior to ending up in hospital for heart.
Dr stated he felt tired, weak, headache, within 24 hours of receiving flu shot. Signs/symptoms now resolved. S/S lasted approximately 4 days. Did not seek treatment. Took acetaminophen only.
Full body rash, high fever 102.9, nausea, aches and pains, swelling at injection site, bruising and swelling traveled down arm.
Gastrointestinal distress, diarrhea lasting 2-3 days post vaccine, started within 6 hours. Tinnitus in left ear, constant- started 2 weeks post first vaccine.
Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039B21A, 031A21A and 058F21A) for COVID-19 vaccination. No Medical History information was reported.On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form.On 02-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). On 09-May-2021, INFLUENZA LIKE ILLNESS (Flu like symptoms) had resolved. It was reported that to help with the symptoms she laid down and rested.No concomitant medications were mentioned.No treatment details were reported.This case was linked to MOD-2021-395956 (Patient Link).
Less than 24 hrs after injection, redness & swelling had occured which started from injection site to elbow(5")wrapping around to anterior bicep(4").Itching and warmth also present at injection site.Symptoms went away 8 hrs after treatment.
Has been on current dose of 108g CONCERTA for yrs. No new meds. Only new thing was vaccine today. Several hours s/p - began c/o of twitching in neck only. Gotten a little worse. No changes in mentation. No hx of tics or fam hx of tics. Will monitor over next few days.
My period started 2 weeks early, the day after the shot, within 4 hours of receiving the shot I began to experience diarrhea that lasted for 48 hours. Within 24 hours of the shot I was in excruciating pain and doubled over with vomiting. I went to the emergency room and was treated with little relief for the pain. The following month the day my period started I was again in excruciating pain and vomiting, again I went to the emergency room and was was treated for pain with no relief. This is my third period since the shot and I find myself again in excruciating pain with no relief in sight. *I was not told that the vaccine contained Latex, if I was told I would have avoided it.*
Systemic: Chills-Mild, Systemic: Confusion-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Exhaustion / Lethargy-Mild, Systemic: Fainting / Unresponsive-Mild, Systemic: Hyperventilation-Mild, Additional Details: PATIENT FELT DIZZY AND LIGHTHEADED ABOUT 5 MINS AFTER ADMINISTRATION OF THE VACCINE. THEN PATIENT FELT SLIGHTLY BETTER ONLY FOR A FEW MOMENTS THEN NOTIFIED THAT SHE WASN'T FEELING GOOD AT ALL. I TRIED TO HAVE PATIENT ELEVATE HER LEGS UP ON A CHAIR BUT WHEN SHE STOOD UP, SHE IMMEDIATELY DROPPED, ALMOST LOOSING CONSCIOUSNESS BUT I WAS THERE TO CATCH HER AND GENTLY LAY HER ON THE GROUND. THE PARAMEDICS WERE IMMEDIATELY NOTIFIED. PRIOR TO THEIR ARRIVAL, SHE WAS CONSCIOUS AND FEELING BETTER.
This spontaneous report as received from a nurse refers to a total number of six patients of unspecified age and gender. No concurrent conditions, historical conditions or concomitant therapies were reported. The reporter stated that at different times since January 2016 through 18-JUL-2016, the patients were vaccinated with improperly stored VARIVAX lot # L013826, expiration date 21-APR-2017 (dose and route of administration not provided). It was reported that the vaccine was stored in 26.5 F for 3 hours and previously in 46F for 50 hours 20 minutes. The temperature excursion was captured via a Data Logger. No adverse effects were reported. Additional information had been requested.
High Fever over 105 for three days Pneumonia Diagnosis Rapid Breathing Vomiting
Information has been received from a medical assistant concerning a 71 year old male patient with gout, elevated blood pressure and cholesterol and allergy to an unknown antibiotic, who on 14-FEB-2007 was vaccinated with a dose of ZOSTAVAX (Merck) (Lot # 656608/0032U EXP 19-JUN-2008) SQ. Concomitant therapy included allopurinol and colchicine. The medical assistant reported that on 04-JAN-2011 the patient had an outbreak of shingles. The outbreak had appeared on the left buttocks near the hip and in the left underarm area. The left side of the chest was tender. The patient was treated with ZOVIRAX and CALADRYL. There were no lab diagnosis/studies performed. The patient sought unspecified medical attention. At the time of the report, the patient had not recovered. Additional information has been requested.
Sore arm, vertigo, double vision, muscles aches, pains, nausea, severe headache
Covid-19 vaccine was not fully administered to the arm of the patient; in the course of administering vaccine, there was a drippage in the needle or leakage of a few drops when the needle was extracted from the injection site; 1 syringe has a leakage; in the course of administering vaccine, there was a drippage in the needle or leakage of a few drops when the needle was extracted from the injection site; This is a spontaneous report. A contactable other healthcare professional (hcp) reported that a male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date not reported), via an unspecified route of administration on an unspecified date at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Reporter stated that they operate a vaccine clinic, and 1 syringe has a leakage, and asked for the reason why the whole dosage didn't go through the patient. He was calling to see if there were guidelines on how to handle that situation. The scenario was where in the course of administering vaccine, there was a drippage in the needle or leakage of a few drops when the needle was extracted from the injection site. Reporter was asking if there's guidelines on how to handle with that situation. The Covid-19 vaccine was not fully administered to the arm of the patient. The outcome of the events was unknown.   Information about lot/batch number has been requested.
PT HAS COMPLAINTS OF NAUSEA, VOMITING X3, DIARRHEA X2 (WATERY), CHILLS, AND STOMACH CRAMPING.  SYMPTOMS SHOWED WITHIN AN HOUR AND A HALF OF GETTING SHOT.  PT STATES HE ATE BURGER KING BEFORE HE RECEIVED THE TYPHOID SHOT.  PT GIVEN PHENERGAN PO TAB AT THIS TIME AND 24 HRS SIQ.
Hands tingling, chest pain, body aches, joint pain, hot flashes, shooting pain in chest and extremities, fever, sweating, abdominal cramps, gas. Pain also at injection site and swelling.
No additional AE's; The vaccine that underwent a temperature excursion (2C to 8C (12.6C) for 480 hours) and was administered.; This spontaneous report was received from an office manager and refers to a patient of an unknown age and gender. No information regarding the patient's medical history, concurrent conditions, concomitant medication, drug reactions or allergies was not reported.  On 06-MAY-2021, the patient was vaccinated with an improperly stored dose of HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) lot # 1687290 was confirmed to be valid, expiration date 06-SEP-2022 (dose, route and site of administration were not reported) for prophylaxis. The temperature excursion was reported as "2 degrees Celsius (C) to 8 C (12.6 C) for 480 hours. There was no previous temperature excursion. No additional adverse event was reported. The call was because of a digital data logger.  This is one of three reports received from the same reporter. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: 1687290; expirationdate: 06-SEP-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability; Sender's Comments:  US-009507513-2105USA003665:
Information has been received from a registered nurse concerning a patient who "two to three weeks ago" was vaccinated with Pneumovax 23 (lot # 650541/1004P).  Subsequently, the patient experienced redness and soreness around the injection site.  Subsequently, the patient recovered.  This report also involved two other patients, for a total of three, and it was reported that "two of the patients developed a fever."  Additional information has been requested.
Patient started having aching pain where flu shot was given starting 2 hours after vaccination. As the day went on the pain worsened. Pain spread to whole shoulder, arm pit, whole arm, and up to the neck. Patient has had constant pain since.
last one was more painful; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Previously administered products included Shingles vaccine (1st dose received on unknown date) and Moderna Covid-19 vaccine (Received on unknown date).   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain. On an unknown date, the outcome of the pain was unknown.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient did not have shingles. The patient received the two doses and after last dose was more painful than the Moderna Coivd-19 vaccine.
Arthritic pains/took COVID booster shot and felt it affected rheumatoid arthritis and caused to feel pain in hands and legs; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Arthritic pains/took COVID booster shot and felt it affected rheumatoid arthritis and caused to feel pain in hands and legs) in an elderly male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    The patient's past medical history included COVID-19 (In 2020, the patient experienced COVID.) in 2020.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form On an unknown date, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form and dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. and ADALIMUMAB (HUMIRA) (Subcutaneous) Citrate free. On an unknown date, the patient experienced ARTHRALGIA (Arthritic pains/took COVID booster shot and felt it affected rheumatoid arthritis and caused to feel pain in hands and legs). At the time of the report, ARTHRALGIA (Arthritic pains/took COVID booster shot and felt it affected rheumatoid arthritis and caused to feel pain in hands and legs) had resolved.            No concomitant medications were reported.  It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. On an unknown date, patient received COVID-19 Vaccine manufactured by Moderna. The reporter's causality for the event of arthralgia was no reasonable possibility with HUMIRA.  No treatment medications were reported.  This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in.
heart started beating fast; lumps grow up on my arm; short of breath; kind of weak; uncomfortable feeling; This is a spontaneous report from a Pfizer sponsored program. A contactable nurse (patient) reported a 41-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL1284) via unspecified route on right deltoid single dose for COVID-19 immunization on 03Jan2021, at 41-year-old. No medical history. Concomitant medication was reported but unspecified. After the patient had received the shot (Jan2021), her heart started beating fast, felt lumps grow up on her arm and became little short of breath. That went away rather quickly, about within 3 hours and the patient was still kind of weak and just uncomfortable feeling. Action taken for BNT162B2 was not applicable. Outcome of the events heart started beating fast, lumps grow up on her arm, short of breath was resolved in Jan2021; outcome of the other events was unknown. Causality assessment per the reporter was checked as yes.
Severe vertigo. Saw primary care MD and was referred to ENT. ENT placed her on prednisone for immunosupressant action.
No adverse effects reported; Multiple patients were vaccinated with improperly stored ROTATEQ on multiple dates; Information has been received from a medical assistant concerning a patient of unknown age, gender and race. The patient's medical history, drug allergies, previously drug reactions, concurrent conditions and concomitant medications were not reported.  On 05-NOV-2018, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) orally for prophylaxis (lot number N029888 with expiration date in 28-AUG-2019) (strength and anatomical location were not provided).  The Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) was stored at an unknown temperature for an unknown time frame. There was a previous temperature excursion and the call was because of a data logger.  No adverse effects reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-1907USA001849: US-009507513-1907USA001848: US-009507513-1906USA011434: US-009507513-1907USA001793: US-009507513-1907USA001794: US-009507513-1907USA001795: US-009507513-1907USA001796: US-009507513-1907USA001797: US-009507513-1907USA001798: US-009507513-1907USA001799: US-009507513-1907USA001800: US-009507513-1907USA001801: US-009507513-1907USA001802: US-009507513-1907USA001803: US-009507513-1907USA001804: US-009507513-1907USA001805: US-009507513-1907USA001806: US-009507513-1907USA001807: US-009507513-1907USA001808: US-009507513-1907USA001809: US-009507513-1907USA001811: US-009507513-1907USA001812: US-009507513-1907USA001813: US-009507513-1907USA001814: US-009507513-1907USA001815: US-009507513-1907USA001816: US-009507513-1907USA001817: US-009507513-1907USA001818: US-009507513-1907USA001819: US-009507513-1907USA001820: US-009507513-1907USA001821: US-009507513-1907USA001822: US-009507513-1907USA001823: US-009507513-1907USA001824: US-009507513-1907USA001825: US-009507513-1907USA001826: US-009507513-1907USA001827: US-009507513-1907USA001828: US-009507513-1907USA001829: US-009507513-1907USA001830: US-009507513-1907USA001831: US-009507513-1907USA001832: US-009507513-1907USA001833: US-009507513-1907USA001834: US-009507513-1907USA001835: US-009507513-1907USA001836: US-009507513-1907USA001837: US-009507513-1907USA001838: US-009507513-1907USA001839: US-009507513-1907USA001840: US-009507513-1907USA001841: US-009507513-1907USA001842: US-009507513-1907USA001843: US-009507513-1907USA001844: US-009507513-1907USA001845: US-009507513-1907USA001846: US-009507513-1907USA001847: US-009507513-1907USA000952: US-009507513-1907USA000953: US-009507513-1907USA000954: US-009507513-1907USA000959: US-009507513-1907USA000962: US-009507513-1907USA000963: US-009507513-1907USA000964: US-009507513-1907USA000965: US-009507513-1907USA000966: US-009507513-1907USA000967: US-009507513-1907USA000968: US-009507513-1907USA000969: US-009507513-1907USA000970: US-009507513-1907USA000988: US-009507513-1907USA000989:
extreme tiredness/feeling really tired; headache/the headache is quite bad; chills/had some chills, more chills; some arm soreness; I cannot sleep all that day; Coming down with allergies; This is a spontaneous report received from contactable (patient) reported for herself. A 74-years-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number: EN6205, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on 11Mar2021 (age at vaccination was 74 years) as dose 2, single for COVID-19 immunization. The patient's medical history included hypertension and diabetic from an unknown date. Concomitant medications included insulin glargine (LANTUS) taken for an unspecified indication, insulin aspart (NOVOLOG) taken for blood glucose fluctuation (as needed, when her blood sugar level was more than 150), hydrochlorothiazide, triamterene (DYAZIDE) taken for an unspecified indication, amlodipine besilate (NORVASC) taken for an unspecified indication, metoprolol succinate (TOPROL) taken for an unspecified indication and atorvastatin taken for an unspecified indication. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: EM9809, Expiration date: unknown) via an unspecified route of administration, administered at an unspecified anatomical location on an unspecified date (age at vaccination was 74 years) as dose 1, single for COVID-19 immunization. The patient received the second dose of the Pfizer-Biontech COVID-19 vaccine last Thursday and on an unspecified date, the side effects started probably about 7 o'clock, her symptoms getting started and until like the next day was very mild. On an unspecified date, the patient experienced some arm soreness and tiredness that lasted all day long but then she was fine until yesterday evening, when she experienced extreme tiredness, headache and chill, which were continuing. Going to tired and she could not sleep all that day, the next day and did not do anything the whole weekend so she did not require much activity but yesterday she just started from very, yesterday evening, afternoon she started feeling really tired and had some chills, more chills, just really tired. It was better today. It continued with the headache and today the headache was quite bad so she did not know. She asked if that could be still the symptoms from the vaccine or not or related, maybe she was coming down with allergies or something like that. Because the symptoms really got worse to her yesterday and she asked if that was normal. Her concern was headache, chills and tiredness, she knew they were side effects, she just wanted to know if they would be cured. She had used Tylenol to treat the headache and stated that helped. She asked if it was normal to still be having tiredness, headache and chills that continued. The outcome of the events was unknown.  Follow-up attempts completed. No further information expected.
Td given in left deltoid, the pt states had unusual discomfort upon administration. The pt developed discomfort to left arm , left shoulder, left scapular, area 5 hours post vax. Applies heat. Has been taking Tylenol and heat for the last week. Still experiencing pain, no redness increased heat has developed at injection site.
Fever or 101.4 on Saturday 1/30/21   lasting thru Tuesday 2/2/21  99.8 Complaint of chest pain.
Initial unsolicited report received from other company via physician on 21 JANUARY 2015. A patient whose age, gender, medical history and  concomitant medications were not reported, had received a dose of INFLUENZA (batch, route of administration and site of administration were not reported) on an unknown date. On an unspecified date after vaccination, the patient could not breathe. Laboratory investigations and corrective treatments were not reported. At the time of this report the outcome of event was unknown. Documents held by sender: none.
That evening kept itching, could not stop. Next day light rashes, itching was uncontrollable. Went to pharmacy. Bought itch cream and allergy medication as suggested by pharmacist after I told her about the vaccine shot I received. Sunday I was swollen twice the size and could not breath. Went to ER and received a shot and medications from pharmacy, said my respiratory system could have shut down.  Information from medical records state hypertension as finding. msv
No reactions other than a sore arm; Initial information received on 17-Oct-2021 regarding an unsolicited valid Social Media non-serious case received via a consumer/non-health care professional (under reference number: US-SA-SAC20211020001115).  This case involves Adult and unknown gender patient who experienced no reactions other than a sore arm (pain in extremity) while receiving INFLUENZA VACCINE.  The patient's medical history, past medical treatments, concomitant medications, vaccinations and family history were not provided.   It was unknown if the patient had any concomitant disease or risk factor.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiry date not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious no reaction other than a sore arm (pain in extremity) (unknown latency) following the administration of INFLUENZA VACCINE.  It was reported "Got mine and covid (coronavirus disease) booster."  It was unknown if the patient experienced any additional symptoms/events.   It was unknown if there were lab data/results available.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome of event was reported as unknown.  There will be no information on lot number for this case.